Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
—1,092.741,095.951,103.321,094.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
—613.36613.36613.36609.50——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
—1,176.791,176.521,182.251,166.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
—1,755.541,759.231,766.301,746.04——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
—635.15635.20636.89630.09——
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
—848.01852.52855.78849.58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
—217.86217.86219.52217.86——
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
—3,417.353,452.773,536.033,450.39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
—913.36915.10920.43904.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
—1,462.381,461.131,464.531,446.02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
—2,423.142,428.712,448.692,424.63——
Q1 2026 earnings • released • EPS miss -17.38% • Revenue miss -1.99%
See results
UTHR:NASDAQ
United Therapeutics Corp
$564.94
-0.74%
(-4.24) 1D
$564.94
0.00% (0.00)
After hours
Closed: May 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UTHR...
Open
$569.17
High
$573.52
Low
$561.20
Mkt. cap
23.98B
Avg. vol.
551.23K
Volume
371.32K
P/E ratio
20.85
52-wk high
$609.35
52-wk low
$272.12
EPS
$27.09
Beta
0.60
Shares outstanding
42.45M
No. of employees
1K
News stories
From sources across the web
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com
Last report
May 6, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$5.82 / $7.04
-17.38%miss
Revenue / Est. (USD)
781.50M / 797.38M
-1.99%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
798.60M
799.50M
790.20M
781.50M
Cost of goods sold
87.60M
100.90M
103.40M
133.40M
Cost of revenue
87.60M
100.90M
103.40M
133.40M
Research and development expenses
134.00M
127.50M
139.50M
138.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
190.80M
181.80M
189.90M
184.10M
Operating expense
324.80M
309.30M
329.40M
322.30M
Total operating expenses
412.40M
410.20M
432.80M
455.70M
Operating income
386.20M
389.30M
357.40M
325.80M
Other non operating income
3.90M
300.00K
800.00K
-46.30M
EBT including unusual items
408.40M
438.00M
444.00M
318.30M
EBT excluding unusual items
434.10M
433.00M
398.30M
318.30M
Income tax expense
98.90M
99.30M
79.70M
43.40M
Effective tax rate
24.22%
22.67%
17.95%
13.63%
Other operating expenses
-
-
-
-
Net income
309.50M
338.70M
364.30M
274.90M
Net profit margin
38.76%
42.36%
46.10%
35.18%
Earnings per share
6.41
7.16
7.70
5.82
Interest and investment income
51.30M
46.40M
43.20M
41.80M
Interest expense
-7.30M
-3.00M
-3.10M
-3.00M
Net interest expenses
44.00M
43.40M
40.10M
38.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
407.30M
411.20M
380.20M
348.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer